Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

FDA advisory panel votes favorably on Boston Scientific Corp scientific WATCHMAN left atrial appendage closure device


Wednesday, 11 Dec 2013 07:49pm EST 

Boston Scientific Corp:Says FDA circulatory system devices panel of the medical devices advisory committee voted favorably by a majority, Yes: 13, No: 1, that the benefits of the WATCHMAN Left Atrial Appendage Closure device outweigh the risks.Says FDA will take into account the Panel's vote in its decision on approval of the WATCHMAN device.Says it expects a decision from the FDA in the first half of 2014. 

Company Quote

13.02
0.02 +0.15%
9 Jul 2014